426 related articles for article (PubMed ID: 31847897)
21. Cancer nanotechnology: opportunities and challenges.
Ferrari M
Nat Rev Cancer; 2005 Mar; 5(3):161-71. PubMed ID: 15738981
[TBL] [Abstract][Full Text] [Related]
22. Theranostic nanomedicine for cancer detection and treatment.
Fan Z; Fu PP; Yu H; Ray PC
J Food Drug Anal; 2014 Mar; 22(1):3-17. PubMed ID: 24673900
[TBL] [Abstract][Full Text] [Related]
23. Is small smarter? Nanomaterial-based detection and elimination of circulating tumor cells: current knowledge and perspectives.
Gribko A; Künzel J; Wünsch D; Lu Q; Nagel SM; Knauer SK; Stauber RH; Ding GB
Int J Nanomedicine; 2019; 14():4187-4209. PubMed ID: 31289440
[TBL] [Abstract][Full Text] [Related]
24. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
[TBL] [Abstract][Full Text] [Related]
25. What is cancer nanotechnology?
Grobmyer SR; Iwakuma N; Sharma P; Moudgil BM
Methods Mol Biol; 2010; 624():1-9. PubMed ID: 20217585
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic technologies for circulating tumour cells and exosomes.
Shao H; Chung J; Issadore D
Biosci Rep; 2015 Nov; 36(1):e00292. PubMed ID: 26604322
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology advances in brain tumors: the state of the art.
Invernici G; Cristini S; Alessandri G; Navone SE; Canzi L; Tavian D; Redaelli C; Acerbi F; Parati EA
Recent Pat Anticancer Drug Discov; 2011 Jan; 6(1):58-69. PubMed ID: 21110824
[TBL] [Abstract][Full Text] [Related]
28. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract][Full Text] [Related]
29. Nanomedicine and contrast enhanced imaging. Applications in cancer diagnosis and therapy.
Iancu I; Bartos A; Bartos D; Herdean A; Betea I; Szabo B; Breazu C; Ciobanu L; Iancu C; Mitre C
Ann Ital Chir; 2021; 92():105-115. PubMed ID: 34031282
[TBL] [Abstract][Full Text] [Related]
30. Can nanotechnology improve cancer diagnosis through miRNA detection?
Fiammengo R
Biomark Med; 2017 Jan; 11(1):69-86. PubMed ID: 27917642
[TBL] [Abstract][Full Text] [Related]
31. Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer.
Liu M; Tang M; Li M; Gao F; Shi C; Hou J; Zeng W
Anticancer Agents Med Chem; 2016; 16(12):1529-1540. PubMed ID: 26902602
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Devices for Circulating Biomarkers Detection and Quantification.
Bedin C; Crotti S; Tasciotti E; Agostini M
Curr Med Chem; 2018; 25(34):4304-4327. PubMed ID: 29149830
[TBL] [Abstract][Full Text] [Related]
33. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
Ignatiadis M; Lee M; Jeffrey SS
Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
[TBL] [Abstract][Full Text] [Related]
34. Delivering on the promise of early detection with liquid biopsies.
Crosby D
Br J Cancer; 2022 Feb; 126(3):313-315. PubMed ID: 35013576
[TBL] [Abstract][Full Text] [Related]
35. Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.
Wu J; Hu S; Zhang L; Xin J; Sun C; Wang L; Ding K; Wang B
Theranostics; 2020; 10(10):4544-4556. PubMed ID: 32292514
[TBL] [Abstract][Full Text] [Related]
36. Control of tumor markers using nanotechnology.
Gómez-Hens A; Fernández-Romero JM; Aguilar-Caballos MP
Mini Rev Med Chem; 2009 Aug; 9(9):1064-74. PubMed ID: 19689403
[TBL] [Abstract][Full Text] [Related]
37. [Research advancement and prospects of nanotechnology in early diagnosis and treatment of cancer].
Hu DH; Gong P; Ma YF; Cai LT
Ai Zheng; 2009 Sep; 28(9):1000-3. PubMed ID: 19728922
[TBL] [Abstract][Full Text] [Related]
38. Bionanotechnology progress and advances.
Chan WC
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):87-91. PubMed ID: 16399591
[TBL] [Abstract][Full Text] [Related]
39. Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.
Li W; Wang H; Zhao Z; Gao H; Liu C; Zhu L; Wang C; Yang Y
Adv Mater; 2019 Nov; 31(45):e1805344. PubMed ID: 30589111
[TBL] [Abstract][Full Text] [Related]
40. Nanotechnology: Emerging Developments and Early Detection of Cancer. A two-day workshop sponsored by the National Cancer Institute and the National Institute of Standards and Technology, August 30-31 2001, on the National Institute of Standards and Technology Campus, Gaithersburg, MD, USA.
Zullo SJ; Srivastava S; Looney JP; Barker PE
Dis Markers; 2002; 18(4):153-8. PubMed ID: 12590168
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
